Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2025-01-08Clinical Trial Update: A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating the combination of IMM2510 and IMM27M in patients with hepatocellular carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery [Phase 2]
Phase 2 clinical trial evaluating lenvatinib as adjuvant therapy to prevent recurrence after curative surgery in high-risk hepatocellular ca…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver [Phase 2]
Phase 2 clinical trial results update evaluating pevonedistat in combination with chemotherapy for biliary tract cancers (cholangiocarcinoma…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma [Phase 3]
The ABC-HCC trial is a Phase 3 study evaluating atezolizumab plus bevacizumab versus transarterial chemoembolization in intermediate-stage h…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Radiation Major Hepatectomy to Selectively Treat Large Unifocal Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial investigating radiation-assisted major hepatectomy to selectively treat large unifocal hepatocellular carcinoma is …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2025-01-07Clinical Trial Update: TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial comparing transarterial chemoembolization with idarubicin versus doxorubicin emulsion in hepatocellular carcinoma is …
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Microvascular Invasion Artificial Intelligence Prediction Via Contrast-enhanced Ultrasound With Explainability
A completed clinical trial update investigates AI-based prediction of microvascular invasion in hepatocellular carcinoma using contrast-enha…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating Y90-radioembolization with nivolumab in Asians with hepatocellular carcinoma. The study is currentl…
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors [Phase 2]
Phase 2 trial evaluating neoadjuvant dual checkpoint inhibition with cryoablation in relapsed/refractory pediatric solid tumors has complete…
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial evaluating Fruquintinib as second-line therapy after immune checkpoint inhibitors in unresectable hepatocellular carc…
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma [Phase 3]
This is a Phase 3 clinical trial evaluating perioperative hepatocellular carcinoma treatment with a combination of camrelizumab, apatinib, a…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Harms of Hepatocellular Carcinoma Surveillance
A completed clinical trial assessing the adverse harms associated with surveillance for hepatocellular carcinoma.
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance
This clinical trial is investigating circulating tumor mitochondrial DNA as a biomarker to monitor recurrence in patients with hepatocellula…
-
CLINICAL_TRIALS other · 2024-12-30Clinical Trial Update: Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval
Agenus has launched an Expanded Access Program to provide Botensilimab and Balstilimab to patients before regulatory approval. The program t…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: A Comparative Analysis of Ultrasound's Accuracy in Diagnosing HC Using Histopathology as Gold Standard
This clinical trial update reports on a study comparing ultrasound accuracy for diagnosing hepatocellular carcinoma using histopathology as …
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma
This clinical trial update describes evaluating the biomarker AKR1B10 for monitoring postoperative recurrence of hepatocellular carcinoma; t…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Effect of Prehabilitation During the Conversion Therapy on Postoperative Outcomes in Unresectable Hepatocellular Carcinoma [NA]
A clinical trial evaluating prehabilitation during conversion therapy for unresectable hepatocellular carcinoma and its effects on postopera…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Mts105 for Advanced Hepatocellular Carcinoma [Phase 1]
A Phase 1 clinical trial update indicates Mts105 for advanced hepatocellular carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy
A clinical trial evaluating the value of 68Ga-FAPI PET/CT imaging for assessing response to systemic therapy in patients with advanced unres…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: OH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver Cancer [Phase 1]
This clinical trial update reports that OH2, an oncolytic viral therapy, is being evaluated for advanced liver cancer via transarterial infu…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: A Head-to-head Comparison of MRI, CT, 18F-FDGal and 18F-choline in Patients With Hepatocellular Carcinoma [NA]
This clinical trial at the University of Aarhus is recruiting to compare MRI, CT, 18F-FDGal, and 18F-choline imaging in patients with hepato…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: 18F-FDGal PET/CT and PET/MRI in Patients With Hepatocellular Carcinoma [NA]
Ongoing clinical study evaluating 18F-FDGal PET/CT and PET/MRI imaging in hepatocellular carcinoma, currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC [Phase 2]
A Phase 2 clinical trial is evaluating a PD-L1 antibody in combination with bevacizumab and hepatic arterial infusion chemotherapy for advan…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients [NA]
A completed clinical trial evaluating a deep-learning model that combines clinical, biological, and ultrasound data to stratify hepatocarcin…
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients. [Phase 2]
Phase 2 clinical trial evaluating HLX10 and HLX04 alone or with HLX53 for untreated locally advanced or metastatic hepatocellular carcinoma;…